Transport of prion protein across the blood-brain barrier

Experimental Neurology

Volumn 218, Issue 1, 2009, Pages 162-167

  Banks, W A ^a,b   Robinson, Sandra M ^a,b   Diaz Espinoza, R ^c,d   Urayama, A ^c   Soto, C ^c  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^d University of Texas Medical Branch School of Medicine   (United States)

Author keywords

Blood brain barrier; Peptide; Prion; Scrapie; Transport

Indexed keywords

PRION PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD BRAIN BARRIER; BRAIN REGION; CENTRAL NERVOUS SYSTEM; CEREBROSPINAL FLUID; CERVICAL LYMPH NODE; CERVICAL SPINAL CORD; CONTROLLED STUDY; CORPUS STRIATUM; HYPOTHALAMUS; ISOTOPE LABELING; KIDNEY CLEARANCE; LIVER CLEARANCE; LUMBAR SPINAL CORD; MALE; MEMBRANE PERMEABILITY; MOUSE; NEUROPROTECTION; NONHUMAN; PATHOGENESIS; PRION DISEASE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN STABILITY; PROTEIN TRANSPORT; SPLEEN; THALAMUS; VIRUS REPLICATION;

ANIMALS; BLOOD-BRAIN BARRIER; CAPILLARY PERMEABILITY; IODINE ISOTOPES; MALE; MICE; PRIONS; PROTEIN TRANSPORT; TIME FACTORS; TISSUE DISTRIBUTION;

EID: 67349245808     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2009.04.025     Document Type: Article

References (46)

1. Banks W.A., and Kastin A.J. Quantifying carrier-mediated transport of peptides from the brain to the blood. In: Conn P.M. (Ed). Methods in Enzymology 168 (1989), Academic Press, San Diego 652-660
2. Banks W.A., and Broadwell R.D. Blood to brain and brain to blood passage of native horseradish peroxidase, wheat germ agglutinin and albumin: pharmacokinetic and morphological assessments. J. Neurochem. 62 (1994) 2404-2419
3. Banks W.A., Kastin A.J., and Fasold M.B. Differential effect of aluminum on the blood-brain barrier transport of peptides, technetium and albumin. J. Pharmacol. Exp. Ther. 244 (1988) 579-585
4. Banks W.A., Kastin A.J., Huang W., Jaspan J.B., and Maness L.M. Leptin enters the brain by a saturable system independent of insulin. Peptides 17 (1996) 305-311
5. Banks W.A., Ortiz L., Plotkin S.R., and Kastin A.J. Human interleukin (IL) 1α, murine IL-1α and murine IL-1β are transported from blood to brain in the mouse by a shared saturable mechanism. J. Pharmacol. Exp. Ther. 259 (1991) 988-996
6. 1-38 across the blood-brain barrier. J. Pharmacol. Exp. Ther. 267 (1993) 690-696
7. Banks W.A., Kastin A.J., Sam H.M., Cao V.T., King B., Maness L.M., and Schally A.V. Saturable efflux of the peptides RC-160 and Tyr-MIF-1 by different parts of the blood-brain barrier. Brain Res. Bull. 35 (1994) 179-182
8. Banks W.A., Fasold M.B., and Kastin A.J. Measurement of efflux rate from brain to blood. In: Irvine G.B., and Williams C.H. (Eds). Methods in Molecular Biology (1997), Neuropeptides Protocols. Humana Press, Totowa, NJ 353-360
9. Banks W.A., Jaspan J.B., Huang W., and Kastin A.J. Transport of insulin across the blood-brain barrier: saturability at euglycemic doses of insulin. Peptides 18 (1997) 1423-1429
10. Banks W.A., Niehoff M.L., Adessi C., and Soto C. Passage of murine scrapie prion protein across the vascular blood-brain barrier of the mouse. Biochem. Biophys. Res. Commun. 18 (2004) 125-130
11. Blasberg R.G., Fenstermacher J.D., and Patlak C.S. Transport of α-aminoisobutyric acid across brain capillary and cellular membranes. J. Cereb. Blood Flow Metab. 3 (1983) 8-32
12. Bradbury M.W.B., Segal M.B., and Wilson J. Transport of potassium at the blood-brain barrier. J. Physiol. (London) 221 (1972) 617-632
13. Cashion M.F., Banks W.A., and Kastin A.J. Sequestration of centrally administered insulin by the brain: effects of starvation, aluminum, and TNF-α. Hormone Behav. 30 (1996) 280-286
14. Daniel P.M., Love E.R., and Pratt O.E. The effect of age upon the influx of glucose into the brain. J. Physiol. (London) 274 (1978) 141-148
15. Deane R., Wu Z., Sagare A., Davis J., Du Yan S., Hamm K., Xu F., Parisi M., LaRue B., Hu H.W., Spijkers P., Guo H., Song X., Lenting P.J., Van Nostrand W.E., and Zlokovic B. LRP/amyloid beta-peptide interaction mediates differential brain efflux of Abeta isoforms. Neuron 43 (2004) 333-344
16. Deane R., Wu Z., and Zlokovic B.V. RAGE (yin) versus LRP (yang) balance regulates Alzheimer amyloid beta-peptide clearance through transport across the blood-brain barrier. Stroke 35 (2004) 2628-2631
17. DeArmond S.J., Yang S.L., Lee A., Bowler R., Taraboulos A., Groth D., and Prusiner S.B. Three scrapie prion isolates exhibit different accumulation patterns of the prion protein scrapie isoform. Proc. Natl. Acad. Sci. U. S. A. 90 (1993) 6449-6453
18. DeMattos R.B., Bales K.R., Cummins D.J., Paul S.M., and Holtzman D.M. Brain to plasma amyloid-β efflux: a measure of brain amyloid burden in a mouse model of Alzheimer's disease. Science 295 (2002) 2264
19. Giri R., Shen Y., Stins M., Du Yan S., Schmidt A.M., Stern D., Kim K.S., Zlokovic B., and Kalra V.K. Beta-amyloid-induced migration of monocytes across human brain endothelial cells involves RAGE and PECAM-1. Am. J. Physiology 279 (2000) C1772-C1781
20. Glowinski J., and Iversen L.L. Regional studies of catecholamines in the rat brain. I. The disposition of [3H]norepinephrine, [3H]dopamine and [3H]dopa in various regions of the brain. J. Neurochem. 13 (1966) 655-669
21. Gutierrez E.G., Banks W.A., and Kastin A.J. Murine tumor necrosis factor alpha is transported from blood to brain in the mouse. J. Neuroimmunol. 47 (1993) 169-176
22. Kimberlin R.H., Cole S., and Walker C.A. Pathogenesis of scrapie is faster when infection is intraspinal instead of intracerebral. Microbial. Pathogenesis 2 (1987) 405-415
23. LaRue B., Hogg E., Sagare A., Jovanovic S., Maness L., Maurer C., Deane R., and Zlokovic B.V. Method for measurement of the blood-brain barrier permeability in the perfused mouse brain: application to amyloid-beta peptide in wild type and Alzheimer's Tg2576 mice. J. Neurosci. Methods 138 (2004) 233-242
24. Mallucci G., Dickinson A., Linehan J., Klohn P.-C., Brandner S., and Collinge J. Depleting neuronal PrP in prion infection prevents disease and reverses spongiosis. Science 302 (2000) 871-874
25. Maness L.M., Banks W.A., Podlisny M.B., Selkoe D.J., and Kastin A.J. Passage of human amyloid β protein 1-40 across the murine blood-brain barrier. Life Sci. 21 (1994) 1643-1650
26. Maness L.M., Banks W.A., Zadina J.E., and Kastin A.J. Periventricular penetration and disappearance of icv Tyr-MIF-1, DAMGO, tyrosine, and albumin. Peptides 17 (1996) 247-250
27. Maness L.M., Kastin A.J., Farrell C.L., and Banks W.A. Fate of leptin after intracerebroventricular injection into the mouse brain. Endocrinology 139 (1998) 4556-4562
28. Martel C.L., Mackic J.B., McComb J.G., Ghiso J., and Zlokovic B.V. Blood-brain barrier uptake of the 40 and 42 amino acid sequences of circulating Alzheimer's amyloid beta in guinea pigs. Neurosci. Lett. 206 (1996) 157-160
29. Mitsios N., Saka M., Krupinksi J., Pennucci R., Sanfeliu C., Miguel Tura M., Gaffney J., Kumar P., Kumar S., Sullivan M., and Stevin M. Cellular prion protein is increased in the plasma and peri-infarcted brain tissue after acute stroke. J. Neurosci. Res. 85 (2007) 602-611
30. Nasu-Nishimura Y., Taniuchi Y., Nishimura T., Sakudo A., Nakajima K., Ano Y., Sugiura K., Sakaguchi S., Itohara S., and Onodera T. Cellular prion protein prevents brain damage after encephalomyocarditis virus infection in mice. Arch. Virol. 153 (2008) 1007-1012
31. Patlak C.S., Blasberg R.G., and Fenstermacher J.D. Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. J. Cereb. Blood Flow Metab. 3 (1983) 1-7
32. Picard-Hagen N., Gayrard V., Viguie C., Moudjou M., Imbs C., and Toutain P.-L. Prion protein in the cerebrospinal fluid of healthy and naturally scrapie-affected sheep. J. Gen. Virol. 87 (2006) 3723-3727
33. Politopoulou G., Seebach J.D., Schmugge M., Schwarz H.P., and Aguzzi A. Age-related expression of cellular prion protein in human peripheral blood leukocytes. Haematologica 85 (2000) 580-587
34. Prusiner S.B. Cell biology and transgenic models of prion diseases. In: Collinge J., and Palmer M.S. (Eds). Prion Diseases (1997), Oxford University Press, Oxford 130-162
35. Robertson C., Booth S.A., Beniac D.R., Coulthart M.B., Booth T.F., and McNicol A. Cellular prion protein is released on exosomes from activated platelets. Blood 107 (2006) 3907-3911
36. Roucou X., and LeBlanc A.C. Cellular prion protein neuroprotective function: implications in prion disease. J. Mol. Med. 83 (2005) 3-11
37. Segal M.B., Preston J.E., Collis C.S., and Zlokovic B.V. Kinetics and Na independence of amino acid uptake by blood side of perfused sheep choroid plexus. Am. J. Physiology 258 (1990) F1288-F1294
38. Shyu W.C., Lin S.Z., Chiang M.F., Ding D.C., Li K.W., Chen S.F., Yang H.I., and Li H. Overexpression of PrPc by adenovirus-mediated gene targeting reduces ischemic injury in a stroke rat model. J. Neurosci. 25 (2005) 8967-8977
39. Simak J., Holada K., D'Agnillo F., Janota J., and Vostal J.G. Cellular prion protein is expressed on endothelial cells and is released during apoptosis on membrane microparticles found in human plasma. Transfusion 42 (2002) 334-342
40. Soto C., Kascsak R.J., Saborio G.P., Aucouturier P., Wisniewski T., Preilli F., Kascsak R., Mendez E., Harris D.A., Ironside J., Tagliavini F., Carp R.I., and Frangione B. Reversion of prion protein conformational changes by synthetic β-sheet breaker peptides. Lancet 355 (2000) 192-197
41. Spudich A., Frigg R., Killic E., Oesch B., Raeber A., Bassetti C.L., and Hermann D.M. Aggravation of ischemic brain injury by prion protein deficiency: role of ERK-1/-2 and STAT-1. Neruobiol. Dis. 20 (2005) 442-449
42. Triguero D., Buciak J., and Pardridge W.M. Capillary depletion method for quantification of blood-brain barrier transport of circulating peptides and plasma proteins. J. Neurochem. 54 (1990) 1882-1888
43. Volkel D., Zimmerman K., Zerr I., Bodemer M., Lindner T., Turecek P.L., Poser S., and Schwarz H.P. Immunochemical determination of cellular prion protein in plasma from healthy subjects and patients with sporadic CJD or other neurologic diseases. Transfusion 41 (2001) 441-448
44. Weise J., Crome O., Sandau R., Schulz-Schaeffer W., Bahr M., and Zerr I. Upregulation of cellular prion protein (PrPc) after focal ischemia and influence of lesion severity. Neurosci. Lett 372 (2004) 146-150
45. Weise J., Sandau R., Schwarting S., Crome O., and Wrede A. Deletion of cellular prion protein results in reduced Akt activation, enhanced postischemic caspase-3 activation, and markers detected in the brains of mice devoid of prion protein. J. Neurochem. 76 (2006) 565-572
46. White A.R., Collins S.J., Maher F., Jobling M.F., Stewart L.R., Thyer J.M., Beyreuther K., Masters C.L., and Cappai R. Prion protein-deficient neurons reveal lower glutathione reductase activity and increased susceptibility to hydrogen peroxide toxicity. Am. J. Pathology 155 (1999) 1723-1730